CELUW
Celularity Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
– postpartum placenta: the foundation of our science – celularity scientists were the first to recognize the human placenta as an untapped resource for innovation, one which is the basis of celularity innovations in immuno-oncology, hematology, and regenerative medicine. our seminal discovery of unique stem, progenitor, and immune cells from the placenta is the foundation of our dominating intellectual property position. with proprietary platform technology and operational expertise to harness the power of this remarkable organ, we developed a deep therapeutic pipeline across a broad range of indications. – amplifying the body’s ability to regenerate – celularity combines innovative assets and research in cell therapy, functional regeneration, and biosourcing to develop leading therapeutic products and services that treat serious, life-threatening diseases. we are harnessing the unique cells and biomaterials from the postpartum placenta to provide therapies that amplify the body’s abil
Market Cap: 931 Million
Primary Exchange: NASDAQ
Website: celularity.com
Shares Outstanding: 216 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 585 trading days
From: 2022-04-20 To: 2024-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|